329 related articles for article (PubMed ID: 27839741)
1. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
[TBL] [Abstract][Full Text] [Related]
2. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
[TBL] [Abstract][Full Text] [Related]
3. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.
Petri H; Nevitt A; Sarsour K; Napalkov P; Collinson N
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):390-5. PubMed ID: 25132663
[TBL] [Abstract][Full Text] [Related]
4. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
5. Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
Faurschou M; Ahlström MG; Lindhardsen J; Obel N; Baslund B
J Rheumatol; 2017 Jan; 44(1):78-83. PubMed ID: 27744394
[TBL] [Abstract][Full Text] [Related]
6. Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.
Michet CJ; Achenbach SJ; Crowson CS; Matteson EL
Semin Arthritis Rheum; 2015 Aug; 45(1):70-4. PubMed ID: 25824865
[TBL] [Abstract][Full Text] [Related]
7. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid Arthritis.
Wilson JC; Sarsour K; Gale S; Pethö-Schramm A; Jick SS; Meier CR
Arthritis Care Res (Hoboken); 2019 Apr; 71(4):498-511. PubMed ID: 29856128
[TBL] [Abstract][Full Text] [Related]
9. Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.
Udayakumar PD; Chandran AK; Crowson CS; Warrington KJ; Matteson EL
J Rheumatol; 2014 Dec; 41(12):2447-51. PubMed ID: 25320223
[TBL] [Abstract][Full Text] [Related]
10. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
Li L; Neogi T; Jick S
Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
[TBL] [Abstract][Full Text] [Related]
11. Incidence of infections in patients with giant cell arteritis: a cohort study.
Durand M; Thomas SL
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):581-8. PubMed ID: 22184094
[TBL] [Abstract][Full Text] [Related]
12. Infections and the risk of incident giant cell arteritis: a population-based, case-control study.
Rhee RL; Grayson PC; Merkel PA; Tomasson G
Ann Rheum Dis; 2017 Jun; 76(6):1031-1035. PubMed ID: 27895041
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis.
Broder MS; Sarsour K; Chang E; Collinson N; Tuckwell K; Napalkov P; Klearman M
Semin Arthritis Rheum; 2016 Oct; 46(2):246-252. PubMed ID: 27378247
[TBL] [Abstract][Full Text] [Related]
14. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.
Ungprasert P; Upala S; Sanguankeo A; Warrington KJ
Mod Rheumatol; 2016; 26(3):410-4. PubMed ID: 26381748
[TBL] [Abstract][Full Text] [Related]
15. Mortality in Patients With Giant Cell Arteritis: A Cohort Study in UK Primary Care.
Li L; Neogi T; Jick S
Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1251-1256. PubMed ID: 29409137
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.
Schmidt J; Smail A; Roche B; Gay P; Salle V; Pellet H; Duhaut P
Arthritis Rheumatol; 2016 Jun; 68(6):1477-82. PubMed ID: 26815885
[TBL] [Abstract][Full Text] [Related]
17. Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.
Wu J; Keeley A; Mallen C; Morgan AW; Pujades-Rodriguez M
CMAJ; 2019 Jun; 191(25):E680-E688. PubMed ID: 31235489
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
[TBL] [Abstract][Full Text] [Related]
19. Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
Scand J Rheumatol; 2013; 42(6):487-97. PubMed ID: 23815287
[TBL] [Abstract][Full Text] [Related]
20. Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases.
Muller G; Devilliers H; Besancenot JF; Manckoundia P
Geriatr Gerontol Int; 2016 Jun; 16(6):679-85. PubMed ID: 26081629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
